Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Best hypnotic drug choice for rapid sequence induction in the operating room
2024-517582-16-00Phase 3Authorised
- Sponsor
- CHU de Nantes
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial comparing Ketamine arm, Propofol arm and Ketamine + propofol arm (3 arms). Primary endpoint: Composite primary outcome. Planned start Apr 2025; status: authorised.
02
Drugs
ketaminepropofol
Beyond the preview
Go deeper on 2024-517582-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517582-16-00.